Tony Wood
-
Upper Providence’s GSK Bets Big on ‘Game-Changing’ Liver Disease Drug
GSK has announced a $1.2 billion deal to acquire efimosfermin alfa from Boston Pharmaceuticals, writes John George for the Philadelphia…
-
GSK, Merck Kick Off New Year with Mergers and Acquisitions Worth Billions
GlaxoSmithKline and Merck, both with significant operations in Montgomery County, have started this year with billions of dollars in mergers…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
